OXURION: Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO
CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the signing of a letter of intent (LOI) for the ...
Actusnews14h
Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO
Communiqué de la société OXURION du 18/03/2025 - Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO ...
Targeted Oncology16h
Mirvetuximab Shows Lasting Survival Benefit in Resistant Ovarian Cancer
Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
Healio1d
Filgotinib well-tolerated, efficacious for up to 8 years in rheumatoid arthritis
Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...
Medindia4d
ELAHERE (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE� (mirvetuximab soravtansine-gynx) in women with folate ...
Central News Agency (CNA)6d
Corona Cero Becomes the Official Global Beer Sponsor of the World Surf League (WSL) in a Landmark Partnership™
First-ever global no-alcohol beer partnership in WSL history will enhance moments of relaxation and celebration for athletes and fans LISBON, Portugal -- (BUSINESS WIRE) -- Today, Corona Cero, the ...